Skip to main content

HHS Releases New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder

Source
U.S. Department of Health and Human Services
Date
Apr 27, 2021
Summary
The U.S. Department of Health and Human Services (HHS) released new practice guidelines that exempt eligible healthcare providers from federal certification and training requirements to obtain a waiver to treat up to 30 patients with buprenorphine. These actions aim to increase access to treatment for opioid use disorder during the COVID-19 pandemic.
Tagged as
Access · Health occupations · Illicit drug use · Licensure and certification of health professionals · Substance use and misuse · Wellness, health promotion, and disease prevention